Abstract 4498: Role of Self-Expanding Drug-Eluting Axxess Stent in Bifurcation Lesions: Intravascular Ultrasound Findings of AXXESS, AXXENT and DIVERGE Trials

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Bon-Kwon Koo ◽  
Takao Hasegawa ◽  
Akiyoshi Miyazawa ◽  
Hyeonsoo Chang ◽  
Junya Ako ◽  
...  

Backgrounds Bifurcation location remains one of the most challenging lesion subsets even in the era of drug-eluting stents. AXXESS stent is a self-expanding drug-eluting stent designed to be placed in the proximal part of the main vessel, at the level of the carina. This stent has flared configuration so as to properly expand into the bifurcation anatomy. This study was performed to assess the efficacy of the AXXESS stent on the treatment of left main and non-left main bifurcation lesions using intravascular ultrasound (IVUS). Methods Volumetric IVUS data from 3 multi-center trials using AXXESS stent in bifurcation lesions (AXXESS trial: non-left main bifurcation, N=37, AXXENT trial: left main bifurcation, N=21 and DIVERGE trial: non-left main bifurcation, N=56) were analyzed. All IVUS analyses were performed at an independent core laboratory. To adjust the difference in length of measured segments, the parameter of volume index was derived from each volume parameter using the formula of volume/measured length (mm 3 /mm). Percent neointimal volume was defined as neointimal volume divided by stent volume. Results During follow-up, AXXESS stent volume index was increased by 27.6±20.2% (from 8.5±2.8 to 10.6±3.3mm 3 /mm). Percent neointimal volume obstruction was 3.4±4.2%. Lumen volume index was increased by 22.4±19.9% (from 8.5±2.8 to 10.3±3.2mm 3 /mm). Patients with 9 month follow-up IVUS had more NIV obstruction than with 6 month follow up (4.3±5.0 vs. 2.5±3.0%, p=0.03). There was a trend toward more stent expansion in non-left main bifurcation lesions than in left main bifurcation lesions (30±16% vs. 19±29%, P=0.1). However, percent neointimal volume obstruction was not different according to the location of lesions (P=0.5). Late acquired incomplete stent apposition was occurred in only 1 case. Conclusion This combined IVUS analysis suggests that AXXESS stent seems to be an effective treatment option for wide range of bifurcation lesion morphologies.

2007 ◽  
Vol 120 (7) ◽  
pp. 545-551 ◽  
Author(s):  
Lei GE ◽  
Cosgrave John ◽  
Iakovou Ioannis ◽  
Ju-ying QIAN ◽  
Agostoni Pierfrancesco ◽  
...  

2009 ◽  
Vol 5 (4) ◽  
pp. 432-437 ◽  
Author(s):  
Corrado Tamburino ◽  
Salvatore Tomasello ◽  
Davide Capodanno ◽  
Maria Di Salvo ◽  
Francesco Marzà ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
K Tani ◽  
S Mitomo ◽  
K Tanaka ◽  
S Tahara ◽  
S Nakamura

Abstract Background/Introduction Limited data exist regarding procedural strategy and clinical outcomes after percutaneous coronary intervention (PCI) for unprotected left main (LM) trifurcation lesion. Purpose The aim of this study is to evaluate 1-year clinical outcomes after LM trifurcation PCI comparing different strategies in kissing balloon inflation (KBI). Methods From 1, January, 2011 to 31, March, 2017, patients who underwent LM trifurcation PCI with second generation drug-eluting stent in our center were retrospectively analyzed. They were categorized into single-stent KBT group (KBT in left anterior descending artery [LAD] and left circumflex artery [LCX], or LAD and high lateral branch [HL]) and no-KBT group. Primary endpoint is restenosis in the lesions. Results Among 1301 patients who underwent LM PCI during the study period, 163 patients (12.5%) had a trifurcation lesion. Regarding the number of stents used for the lesions, 1, 2 and 3 stents were used in 75.4%, 22.0% and 2.5%, respectively. Median follow-up period of LM trifurcation patients was 265 days (interquartile range: 81–564). In the no-KBT group (64 patients), 19 patients experienced restenosis of HL and LCX (HL: 8 patients, LCX: 0 patient, and both: 11 patients). In the KBT-group, KBT for LAD and LCX was performed in 47 patients, and of them, 19 patients experienced restenosis of LM-LAD, HL and LCX (HL: 12 patients, LCX: 6 patients and all: 1 patient). On the other hand, in 9 patients with KBT for LAD and HL, there were no restenosis cases at 1-year follow-up. There was no statistically significant difference in restenosis rate between the no-KBI and KBT group (29.6% vs. 40.4%, p=0.69). Restenosis rates in each segments Conclusion After LM trifurcation PCI, restenosis rate at 1-year follow-up was high, and no difference between no-KBT and KBT group overall. However, there was no restenosis case in patients with KBT for LAD and HL.


Sign in / Sign up

Export Citation Format

Share Document